OncoSec Medical (ONCS) Stock Forecast, Price & News

OncoSec Medical (NASDAQ:ONCS) Frequently Asked Questions

Is OncoSec Medical a buy right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for OncoSec Medical in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" OncoSec Medical stock.
View analyst ratings for OncoSec Medical or view top-rated stocks.

When is OncoSec Medical's next earnings date?

OncoSec Medical is scheduled to release its next quarterly earnings announcement on Friday, June 10th 2022.
View our earnings forecast for OncoSec Medical.

How were OncoSec Medical's earnings last quarter?

OncoSec Medical Incorporated (NASDAQ:ONCS) posted its quarterly earnings data on Tuesday, March, 15th. The biotechnology company reported ($0.25) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.11) by $0.14.
View OncoSec Medical's earnings history.

When did OncoSec Medical's stock split? How did OncoSec Medical's stock split work?

OncoSec Medical's stock reverse split before market open on Tuesday, May 21st 2019. The 1-10 reverse split was announced on Monday, May 20th 2019. The number of shares owned by shareholders was adjusted after the closing bell on Monday, May 20th 2019. An investor that had 100 shares of OncoSec Medical stock prior to the reverse split would have 10 shares after the split.

What price target have analysts set for ONCS?

1 brokers have issued twelve-month price objectives for OncoSec Medical's shares. Their forecasts range from $5.00 to $5.00. On average, they anticipate OncoSec Medical's stock price to reach $5.00 in the next twelve months. This suggests a possible upside of 521.0% from the stock's current price.
View analysts' price targets for OncoSec Medical or view top-rated stocks among Wall Street analysts.

Who are OncoSec Medical's key executives?

OncoSec Medical's management team includes the following people:

• Mr. Robert J. DelAversano CPA, VP of Fin. and Principal Accounting Officer & Controller (Age 50, Pay $361.18k) (LinkedIn Profile)
• Dr. Robert H. Arch Ph.D., Pres & CEO
• Mr. George Chi C.F.A., CPA, Chief Financial Officer (Age 52)
• Dr. Kim Jaffe, Assistant VP of Bus. Devel. & Operations
• Mr. Tu Diep M.Sc., Sr. VP & Head of Operations
• Dr. Sandra Aung Ph.D., Sr. VP & Chief Clinical Devel. Officer
• Dr. Mai Hope Le M.D., Consultant (Age 46)

What is Punit Dhillon's approval rating as OncoSec Medical's CEO?

2 employees have rated OncoSec Medical CEO Punit Dhillon on Glassdoor.com. Punit Dhillon has an approval rating of 50% among OncoSec Medical's employees. This puts Punit Dhillon in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of OncoSec Medical's key competitors?

Some companies that are related to OncoSec Medical include ORIC Pharmaceuticals (ORIC), CorMedix (CRMD), ContraFect (CFRX), CorMedix (CRMD), Pieris Pharmaceuticals (PIRS), RVL Pharmaceuticals (RVLP), Adagene (ADAG), Applied Molecular Transport (AMTI), Nabriva Therapeutics (NBRV), Sol-Gel Technologies (SLGL), MediciNova (MNOV), Annexon (ANNX), 9 Meters Biopharma (NMTR), Shattuck Labs (STTK) and Werewolf Therapeutics (HOWL).
View all of ONCS's competitors.

What other stocks do shareholders of OncoSec Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other OncoSec Medical investors own include Cytokinetics (CYTK), Inovio Pharmaceuticals (INO), XOMA (XOMA), Anavex Life Sciences (AVXL), Walt Disney (DIS), Idera Pharmaceuticals (IDRA), Sorrento Therapeutics (SRNE), Amarin (AMRN), Dynavax Technologies (DVAX) and Trevena (TRVN).

What is OncoSec Medical's stock symbol?

OncoSec Medical trades on the NASDAQ under the ticker symbol "ONCS."

Who are OncoSec Medical's major shareholders?

OncoSec Medical's stock is owned by a number of institutional and retail investors. Top institutional investors include Bank of New York Mellon Corp (0.98%), Salzhauer Michael (0.75%), Renaissance Technologies LLC (0.12%), Sandbox Financial Partners LLC (0.07%), Simplex Trading LLC (0.00%) and Concourse Financial Group Securities Inc. (0.00%). Company insiders that own OncoSec Medical stock include Alpha Holdings, Inc, Brian A Leuthner, Daniel J O'connor, Grand Pharmaceutical & H China, Robert J Delaversano, Robert J Delaversano and Yuhang Zhao.
View institutional ownership trends for OncoSec Medical.

Which institutional investors are selling OncoSec Medical stock?

ONCS stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Sandbox Financial Partners LLC, Salzhauer Michael, and Simplex Trading LLC. Company insiders that have sold OncoSec Medical company stock in the last year include Brian A Leuthner, and Robert J Delaversano.
View insider buying and selling activity for OncoSec Medical or view top insider-selling stocks.

Which institutional investors are buying OncoSec Medical stock?

ONCS stock was acquired by a variety of institutional investors in the last quarter, including Bank of New York Mellon Corp. Company insiders that have bought OncoSec Medical stock in the last two years include Grand Pharmaceutical & H China, and Yuhang Zhao.
View insider buying and selling activity for OncoSec Medical or or view top insider-buying stocks.

How do I buy shares of OncoSec Medical?

Shares of ONCS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is OncoSec Medical's stock price today?

One share of ONCS stock can currently be purchased for approximately $0.81.

How much money does OncoSec Medical make?

OncoSec Medical has a market capitalization of $31.68 million. The biotechnology company earns $-45.17 million in net income (profit) each year or ($1.04) on an earnings per share basis.

How many employees does OncoSec Medical have?

OncoSec Medical employs 54 workers across the globe.

What is OncoSec Medical's official website?

The official website for OncoSec Medical is www.oncosec.com.

How can I contact OncoSec Medical?

OncoSec Medical's mailing address is 3565 GENERAL ATOMICS COURT, SAN DIEGO CA, 92121. The biotechnology company can be reached via phone at (858) 662-6732, via email at [email protected], or via fax at 858-430-3832.